About Toku Eyes
Toku Eyes is a company based in Auckland (New Zealand) founded in 2018 by David Squirrell and Ehsan Vaghefi was acquired by Topconhealthcare in October 2025.. Toku Eyes has raised $10.54 million across 2 funding rounds from investors including National Vision, KeraLink International and Topconhealthcare. Toku Eyes operates in a competitive market with competitors including Visionix, Quantel Medical, TearLab, Cassini and Pr3vent, among others.
- Headquarter Auckland, New Zealand
- Founders David Squirrell, Ehsan Vaghefi
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Toku Eyes Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.54 M (USD)
in 2 rounds
-
Latest Funding Round
$8 M (USD), Series A
Apr 17, 2023
-
Investors
National Vision
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Topconhealthcare
(Oct 17, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Toku Eyes
Toku Eyes has successfully raised a total of $10.54M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $8.0M
-
First Round
First Round
(29 Jun 2021)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Series A - Toku Eyes | Valuation | National Vision , Topconhealthcare |
|
| Jun, 2021 | Amount | Seed - Toku Eyes | Valuation | Icehouse Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Toku Eyes
Toku Eyes has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include National Vision, KeraLink International and Topconhealthcare. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE fund focused on high growth companies of New Zealand
|
Founded Year | Domain | Location | |
|
Retailer of eyewear products
|
Founded Year | Domain | Location | |
|
Offers medical devices and software for ophthalmic diagnostics and patient care.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Toku Eyes
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Toku Eyes
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Toku Eyes Comparisons
Competitors of Toku Eyes
Toku Eyes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Visionix, Quantel Medical, TearLab, Cassini and Pr3vent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic, screening, and lens finishing equipment for eye care
|
|
| domain | founded_year | HQ Location |
Ultrasound and laser devices for ophthalmology are manufactured and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic tests for detecting hyperosmolarity
|
|
| domain | founded_year | HQ Location |
Corneal diagnostic solutions for astigmatism and topography are offered.
|
|
| domain | founded_year | HQ Location |
AI-based platform for newborn ophthalmic condition screening is offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Toku Eyes
Frequently Asked Questions about Toku Eyes
When was Toku Eyes founded?
Toku Eyes was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Where is Toku Eyes located?
Toku Eyes is headquartered in Auckland, New Zealand.
Who is the current CEO of Toku Eyes?
Ehsan Vaghefi is the current CEO of Toku Eyes. They have also founded this company.
Is Toku Eyes a funded company?
Toku Eyes is a funded company, having raised a total of $10.54M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.54M, raised on Jun 29, 2021.
What does Toku Eyes do?
Toku Eyes was founded in 2018 in Auckland, New Zealand, within the health technology sector. Retinal image analysis tools powered by artificial intelligence are developed to identify indicators of conditions such as cardiovascular risk and chronic kidney disease. Non-invasive, real-time assessments are enabled by the technology, with products requiring regulatory approvals that vary by region. Operations focus on facilitating earlier diagnosis through these AI-driven solutions.
Who are the top competitors of Toku Eyes?
Who are Toku Eyes's investors?
Toku Eyes has 5 investors. Key investors include National Vision, KeraLink International, Topconhealthcare, Icehouse Ventures, and Artemis Capital Management.